EX-FILING FEES
Published on October 6, 2023
Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Acasti Pharma Inc.
(Exact Name of Registrant as Specified in Its Charter)
Table 1: Newly Registered and Carry Forward Securities
|
|
Security Type
|
|
Security Class Title
|
|
Fee Calculation or Carry Forward Rule
|
|
Amount Registered (1)
|
|
Proposed Maximum Offering Price per Share (2)
|
|
Maximum Aggregate Offering Price (1)
|
|
Fee Rate
|
|
Amount of Registration Fee |
|
Carry Forward Form Type |
|
Carry Forward File Number |
|
Carry Forward Initial Effective Date |
|
Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
Newly Registered Securities |
||||||||||||||||||||||||
Fees to be Paid |
|
Equity |
|
Common Shares, no par value per share |
|
Rule 457(c) |
|
6,594,615 |
|
$2.68 |
|
$17,673,568.20 |
|
$147.60 per million |
|
$2,608.62 |
|
- |
|
- |
|
- |
|
- |
Fees Previously Paid |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
Carry Forward Securities |
||||||||||||||||||||||||
Carry Forward Securities |
|
- |
|
- |
|
- |
|
- |
|
|
|
- |
|
|
|
|
|
- |
|
- |
|
- |
|
- |
|
|
Total Offering Amounts |
|
|
|
$17,673,568.20 |
|
|
|
$2,608.62 |
|
|
|
|
|
|
|
|
||||||
|
|
Total Fees Previously Paid |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
||||||
|
|
Total Fee Offsets |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
||||||
|
|
Net Fee Due |
|
|
|
|
|
|
|
$2,608.62 |
|
|
|
|
|
|
|
|
(1) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement also covers any additional securities that may be offered, issued or become issuable in connection with any stock split, stock dividend or similar transaction or pursuant to anti-dilution provisions of any of the securities. |
(2) |
Estimated solely for the purpose of calculation of the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $2.68, the average of the high and low reported sales prices of the registrant’s common stock on the Nasdaq Capital Market on October 3, 2023. |
MACROBUTTON DocID \\4125-9201-7227 v1